CORE-IBD: a multidisciplinary international consensus initiative to develop a core outcome set for randomized controlled trials in inflammatory bowel disease

<p>Background & Aims</p> <p>End points to determine the efficacy and safety of medical therapies for Crohn’s disease (CD) and ulcerative colitis (UC) are evolving. Given the heterogeneity in current outcome measures, harmonizing end points in a core outcome set for randomized c...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Ma, C, Hanzel, J, Panaccione, R, Sandborn, WJ, D'Haens, GR, Ahuja, V, Atreya, R, Bernstein, CN, Bossuyt, P, Bressler, B, Bryant, RV, Cohen, B, Colombel, J-F, Danese, S, Dignass, A, Dubinsky, MC, Fleshner, PR, Gearry, RB, Hanauer, SB, Hart, A, Kotze, PG, Kucharzik, T, Lakatos, PL, Leong, RW, Magro, F, Panés, J, Peyrin-Biroulet, L, Ran, Z, Regueiro, M, Singh, S, Spinelli, A, Steinhart, AH, Travis, SP, van der Woude, CJ, Yacyshyn, B, Yamamoto, T, Allez, M, Bemelman, WA, Lightner, AL, Louis, E, Rubin, DT, Scherl, EJ, Siegel, CA, Silverberg, MS, Vermeire, S, Parker, CE, McFarlane, SC, Guizzetti, L, Smith, MI, Casteele, NV, Feagan, BG, Jairath, V
Andre forfattere: CORE-IBD Collaborators
Format: Journal article
Sprog:English
Udgivet: Elsevier 2022